Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Identification of a Human Airway Epithelial Cell Subpopulation with Altered Biophysical, Molecular, and Metastatic Properties.

Pagano PC, Tran LM, Bendris N, O'Byrne S, Tse HT, Sharma S, Hoech JW, Park SJ, Liclican EL, Jing Z, Li R, Krysan K, Paul MK, Fontebasso Y, Larsen JE, Hakimi S, Seki A, Fishbein MC, Gimzewski JK, Carlo DD, Minna JD, Walser TC, Dubinett SM.

Cancer Prev Res (Phila). 2017 Sep;10(9):514-524. doi: 10.1158/1940-6207.CAPR-16-0335. Epub 2017 Jul 28.

2.

Crosstalk between CLCb/Dyn1-Mediated Adaptive Clathrin-Mediated Endocytosis and Epidermal Growth Factor Receptor Signaling Increases Metastasis.

Chen PH, Bendris N, Hsiao YJ, Reis CR, Mettlen M, Chen HY, Yu SL, Schmid SL.

Dev Cell. 2017 Feb 6;40(3):278-288.e5. doi: 10.1016/j.devcel.2017.01.007.

3.

TRAIL-death receptor endocytosis and apoptosis are selectively regulated by dynamin-1 activation.

Reis CR, Chen PH, Bendris N, Schmid SL.

Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):504-509. doi: 10.1073/pnas.1615072114. Epub 2017 Jan 3.

4.

Endocytosis, Metastasis and Beyond: Multiple Facets of SNX9.

Bendris N, Schmid SL.

Trends Cell Biol. 2017 Mar;27(3):189-200. doi: 10.1016/j.tcb.2016.11.001. Epub 2016 Dec 16. Review.

5.

Sorting nexin 9 negatively regulates invadopodia formation and function in cancer cells.

Bendris N, Stearns CJ, Reis CR, Rodriguez-Canales J, Liu H, Witkiewicz AW, Schmid SL.

J Cell Sci. 2016 Jul 15;129(14):2804-16. doi: 10.1242/jcs.188045. Epub 2016 Jun 8.

6.

SNX9 promotes metastasis by enhancing cancer cell invasion via differential regulation of RhoGTPases.

Bendris N, Williams KC, Reis CR, Welf ES, Chen PH, Lemmers B, Hahne M, Leong HS, Schmid SL.

Mol Biol Cell. 2016 Mar 9. pii: mbc.E16-02-0101. [Epub ahead of print]

7.

Cyclin A2: At the crossroads of cell cycle and cell invasion.

Loukil A, Cheung CT, Bendris N, Lemmers B, Peter M, Blanchard JM.

World J Biol Chem. 2015 Nov 26;6(4):346-50. doi: 10.4331/wjbc.v6.i4.346. Review.

8.

A systematic analysis reveals heterogeneous changes in the endocytic activities of cancer cells.

Elkin SR, Bendris N, Reis CR, Zhou Y, Xie Y, Huffman KE, Minna JD, Schmid SL.

Cancer Res. 2015 Nov 1;75(21):4640-50. doi: 10.1158/0008-5472.CAN-15-0939. Epub 2015 Sep 10.

9.

Cyclin A2 modulates EMT via β-catenin and phospholipase C pathways.

Cheung CT, Bendris N, Paul C, Hamieh A, Anouar Y, Hahne M, Blanchard JM, Lemmers B.

Carcinogenesis. 2015 Aug;36(8):914-24. doi: 10.1093/carcin/bgv069. Epub 2015 May 19.

PMID:
25993989
10.

Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors.

Bendris N, Lemmers B, Blanchard JM.

Cell Cycle. 2015;14(12):1786-98. doi: 10.1080/15384101.2014.998085. Review.

11.

Cyclin A2, a novel regulator of EMT.

Bendris N, Cheung CT, Leong HS, Lewis JD, Chambers AF, Blanchard JM, Lemmers B.

Cell Mol Life Sci. 2014 Dec;71(24):4881-94. doi: 10.1007/s00018-014-1654-8. Epub 2014 May 31.

PMID:
24879294
12.

Cyclin A2: a genuine cell cycle regulator?

Bendris N, Loukil A, Cheung C, Arsic N, Rebouissou C, Hipskind R, Peter M, Lemmers B, Blanchard JM.

Biomol Concepts. 2012 Dec;3(6):535-43. doi: 10.1515/bmc-2012-0027.

PMID:
25436557
13.

Cyclin A2, Rho GTPases and EMT.

Bendris N, Arsic N, Lemmers B, Blanchard JM.

Small GTPases. 2012 Oct-Dec;3(4):225-8. doi: 10.4161/sgtp.20791. Epub 2012 Jun 27.

14.

A novel function for Cyclin A2: control of cell invasion via RhoA signaling.

Arsic N, Bendris N, Peter M, Begon-Pescia C, Rebouissou C, Gadéa G, Bouquier N, Bibeau F, Lemmers B, Blanchard JM.

J Cell Biol. 2012 Jan 9;196(1):147-62. doi: 10.1083/jcb.201102085.

15.

Cyclin A2 mutagenesis analysis: a new insight into CDK activation and cellular localization requirements.

Bendris N, Lemmers B, Blanchard JM, Arsic N.

PLoS One. 2011;6(7):e22879. doi: 10.1371/journal.pone.0022879. Epub 2011 Jul 28.

16.

The Quebec Adolescent Refugee Project: psychopathology and family variables in a sample from 35 nations.

Tousignant M, Habimana E, Biron C, Malo C, Sidoli-LeBlanc E, Bendris N.

J Am Acad Child Adolesc Psychiatry. 1999 Nov;38(11):1426-32.

PMID:
10560230
17.

[Removal of plasma lipids by selective filtration].

Planques Y, Bendris N, Allary M, Lacoste-Bourgeacq JF.

Rev Fr Transfus Hemobiol. 1992 Mar;35(2):95-105. French.

PMID:
1637422

Supplemental Content

Loading ...
Support Center